2BB score and signals
Unicycive Therapeutics, Inc.’s current 2BB score is 15 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 3 | Very Low |
| Momentum | 52 | Stable |
| Financial strength | 35 | Weak |
| Quality | 40 | Normal |
| Risk | 77 | High |
Unicycive Therapeutics, Inc. (UNCY) Stock Score & Signals
Unicycive Therapeutics, Inc. (UNCY) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 15 out of 100.
Company facts
| Founded | 2016 |
| Employees | 22 |
| 52-week range | $3.59 – $8.74 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-29 | — | -0.3351 | — | $374,513.00 |
| 2026-11-10 | — | -0.3191 | — | $0.00 |
| 2026-08-17 | — | -0.343 | — | $0.00 |
| 2026-05-12 | -0.54 | -0.5168 | $0.00 | $0.00 |